A detailed history of Deutsche Bank Ag\ transactions in Cytokinetics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 134,927 shares of CYTK stock, worth $6.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,927
Previous 119,664 12.75%
Holding current value
$6.67 Million
Previous $6.48 Million 9.89%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$51.22 - $60.16 $781,770 - $918,222
15,263 Added 12.75%
134,927 $7.12 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $73,943 - $115,952
-1,545 Reduced 1.27%
119,664 $6.48 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $28.3 Million - $48 Million
-443,942 Reduced 78.55%
121,209 $8.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $9.63 Million - $29.9 Million
358,384 Added 173.33%
565,151 $47.2 Million
Q3 2023

Nov 09, 2023

BUY
$29.46 - $36.61 $166,684 - $207,139
5,658 Added 2.81%
206,767 $6.09 Million
Q2 2023

Aug 14, 2023

SELL
$32.62 - $40.75 $599,131 - $748,455
-18,367 Reduced 8.37%
201,109 $6.56 Million
Q1 2023

May 15, 2023

BUY
$33.36 - $45.71 $849,879 - $1.16 Million
25,476 Added 13.13%
219,476 $7.72 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $654,984 - $935,875
18,311 Added 10.42%
194,000 $8.89 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $3.56 Million - $5.04 Million
92,427 Added 111.01%
175,689 $8.51 Million
Q2 2022

Aug 11, 2022

SELL
$33.93 - $48.92 $144,100 - $207,763
-4,247 Reduced 4.85%
83,262 $3.27 Million
Q1 2022

May 13, 2022

SELL
$29.74 - $46.0 $142,157 - $219,880
-4,780 Reduced 5.18%
87,509 $3.22 Million
Q4 2021

Feb 11, 2022

SELL
$34.35 - $46.38 $1.49 Million - $2.01 Million
-43,300 Reduced 31.93%
92,289 $4.21 Million
Q3 2021

Nov 04, 2021

BUY
$18.54 - $35.74 $732,812 - $1.41 Million
39,526 Added 41.15%
135,589 $4.85 Million
Q2 2021

Aug 11, 2021

BUY
$19.79 - $26.99 $1.02 Million - $1.39 Million
51,585 Added 115.98%
96,063 $1.9 Million
Q1 2021

May 13, 2021

SELL
$18.57 - $25.68 $83,880 - $115,996
-4,517 Reduced 9.22%
44,478 $1.03 Million
Q4 2020

Feb 16, 2021

SELL
$15.26 - $28.61 $2.66 Million - $4.98 Million
-174,029 Reduced 78.03%
48,995 $1.02 Million
Q3 2020

Nov 12, 2020

BUY
$20.58 - $28.96 $447,882 - $630,256
21,763 Added 10.81%
223,024 $4.83 Million
Q2 2020

Aug 13, 2020

SELL
$11.15 - $24.64 $481,111 - $1.06 Million
-43,149 Reduced 17.65%
201,261 $4.74 Million
Q1 2020

May 14, 2020

BUY
$8.75 - $16.3 $435,190 - $810,696
49,736 Added 25.55%
244,410 $2.88 Million
Q4 2019

Feb 14, 2020

BUY
$7.95 - $11.84 $132,717 - $197,656
16,694 Added 9.38%
194,674 $2.06 Million
Q3 2019

Nov 14, 2019

SELL
$10.82 - $14.25 $461,256 - $607,477
-42,630 Reduced 19.32%
177,980 $2.02 Million
Q2 2019

Aug 14, 2019

SELL
$7.95 - $11.25 $226,257 - $320,175
-28,460 Reduced 11.43%
220,610 $2.48 Million
Q1 2019

May 15, 2019

BUY
$5.95 - $10.19 $530,085 - $907,827
89,090 Added 55.69%
249,070 $2.01 Million
Q4 2018

Feb 14, 2019

SELL
$5.91 - $9.29 $708,071 - $1.11 Million
-119,809 Reduced 42.82%
159,980 $1.01 Million
Q3 2018

Dec 21, 2021

BUY
$6.4 - $9.85 $625,894 - $963,290
97,796 Added 53.74%
279,789 $2.76 Million
Q3 2018

Nov 14, 2018

SELL
$6.4 - $9.85 $992,819 - $1.53 Million
-155,128 Reduced 46.02%
181,993 $1.79 Million
Q2 2018

Apr 21, 2020

BUY
$6.9 - $9.9 $755,715 - $1.08 Million
109,524 Added 48.12%
337,121 $2.8 Million
Q2 2018

Aug 14, 2018

SELL
$6.9 - $9.9 $460,312 - $660,448
-66,712 Reduced 22.67%
227,597 $1.89 Million
Q1 2018

Oct 18, 2019

BUY
$7.2 - $10.05 $1.32 Million - $1.84 Million
182,852 Added 164.06%
294,309 $2.12 Million
Q1 2018

May 15, 2018

SELL
$7.2 - $10.05 $463,500 - $646,968
-64,375 Reduced 36.61%
111,457 $800,000
Q4 2017

Feb 14, 2018

BUY
$7.25 - $15.65 $689,685 - $1.49 Million
95,129 Added 117.88%
175,832 $1.43 Million
Q3 2017

Nov 14, 2017

BUY
$12.0 - $15.0 $968,436 - $1.21 Million
80,703
80,703 $1.17 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.66B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.